Orbimed Advisors LLC, a director at Aspen Neuroscience, Inc., purchases $15M of stock

Orbimed Advisors LLC, a director of Aspen Neuroscience, Inc. (ASPE), bought 1,000,000 shares on Nov 2 at an average price of $15.00, a total of about $15 million, according to a Form 4 filed with the SEC on Nov 4.

It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. After the trade, the filing lists 3,589,132 shares held.

Other Aspen Neuroscience, Inc. insiders have also bought: Three insiders made open-market purchases within 14 days, a pattern known as a cluster buy. The trade was reported within two business days, as Section 16 requires.

Details from the SEC filing:

The purchase

Company	Aspen Neuroscience, Inc. (ASPE)
Insider	Orbimed Advisors LLC
Role	Director
Transaction	Open-market purchase (code P)
Shares	1,000,000
Average price	$15.00
Value	$15,000,000
Trade date	Nov 2, 2026
Filed with the SEC	Nov 4, 2026, 6:43 PM ET
Shares held after	3,589,132
Ownership	Indirect
Rule 10b5-1 plan	Not marked in the filing

See more details on this insider purchase

View the Form 4 on SEC.gov

See more large insider purchases · See all the latest insider trades

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.